Does chemoselection open the door for immunotherapy?

Ann Oncol. 2017 Aug 1;28(8):1697-1699. doi: 10.1093/annonc/mdx269.

Authors

M T Jacobs¹, A L Ruiz², E E Cohen¹

Affiliations

¹ Department of Medicine, Division of Oncology, Moores Cancer Center, University of California San Diego, La Jolla, California USA.
² Department of Oncology, Centro Hospitalario Burgos, Burgos, Castilla y León, Spain.

PMID: 28541375
DOI: 10.1093/annonc/mdx269

No abstract available

Publication types

Editorial
Comment

MeSH terms

Humans
Immunotherapy*